Skip to main content
SpringerLink
Log in

Implications of the Canada—USA (CANUSA) multicentre trial

  • Chapter
Textbook of Peritoneal Dialysis

  • 250 Accesses

Abstract

The Canada—USA study of peritoneal dialysis was published in July 1996 [1] and has become the focus of considerable discussion related to the methodology and clinical implications of the results [2–4]. There have been five publications based on the data collected by the CANUSA study group [1, 5–8] as well as two abstracts addressing the clinical impact of peritonitis [9] and the role of residual renal function [10] in this population (Table 1). The clinical implications of the published studies include the association of adequacy of dialysis and nutritional status with clinical outcomes [1], the relationship between residual renal function at initiation of dialysis and clinical outcomes, the clearances of urea and creatinine required to maintain good nutrition [5], outcomes in patients with type I and type II diabetes mellitus [6], reasons for poorer outcomes in patients from the USA compared to Canada [7] and the poorer outcomes in patients with higher peritoneal membrane transport [8].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Churchill DN, Taylor DW, Keshaviah PR for the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198–207.

    Google Scholar 

  2. Blake PG. A critique of the Canada-USA (CANUSA) peritoneal dialysis study. Perit Dial Int 1996; 16: 243–5.

    PubMed  CAS  Google Scholar 

  3. Jindal KK. Commentary on the findings of the CANUSA study. Perit Dial Int 1996; 16: 246–7.

    PubMed  CAS  Google Scholar 

  4. Gotch FA. The CANUSA study. Perit Dial Int 1997; 17 (suppl. 2): S111–14.

    PubMed  Google Scholar 

  5. McKusker FX, Teehan BP, Thorpe KE, Keshaviah PR, Churchill DN for the CANUSA Peritoneal Dialysis Study Group. How much peritoneal dialysis is required for the maintenance of a good nutritional state? Kidney Int 1996; 50 (suppl. 56): S56–61.

    Google Scholar 

  6. Churchill DN, Thorpe KE, Teehan BP for the CANUSA Peritoneal Dialysis Study Group. Treatment of diabetics with end-stage renal disease: lessons from the Canada-USA (CANUSA) study of peritoneal dialysis. Semin Dial 1997; 10: 215–18.

    Article  Google Scholar 

  7. Churchill DN, Thorpe KE, Vonesh EF, Keshaviah PR for the CANUSA Peritoneal Dialysis Study Group. Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. J Am Soc Nephrol 1997; 8: 965–71.

    PubMed  Google Scholar 

  8. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D for the CANUSA Peritoneal Dialysis Study Group. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 1998; 9: 1285–92.

    PubMed  Google Scholar 

  9. Jindal K, Thorpe KE, Lavoie S, Bargman J, Dasgupta M, Churchill DN for the CANUSA Peritoneal Dialysis Study Group. Multivariate analysis of peritonitis in peritoneal dialysis; the CANUSA experience. Perit Dial Int 1996; 16 (suppl. 2): S41.

    Google Scholar 

  10. Bargman JM, Thorpe KE, Churchill DN. The importance of residual renal function for survival in patients on peritoneal dialysis. J Am Soc Nephrol 1997; 8: 185A.

    Google Scholar 

  11. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33: 27–39.

    PubMed  CAS  Google Scholar 

  12. Van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous peritoneal dialysis. J Am Soc Nephrol 1996; 7: 745–50.

    PubMed  Google Scholar 

  13. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight are known. Arch Int Med 1916; 17: 863–71.

    Article  Google Scholar 

  14. Baker JP, Detsky AS, Wesson DE et al Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med 1982; 306: 969–72.

    Article  PubMed  CAS  Google Scholar 

  15. Randerson DH, Chapman GV, Farrell PC Amino acid and dietary status in CAPD patients. In: Atkins RC, Farrell PC, Thompson N, eds. Peritoneal Dialysis. Edinburgh: Churchill-Livingstone, 1981, pp. 180–91.

    Google Scholar 

  16. Keshaviah PR, Nolph KD, Moore HL et al Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 1994; 4: 1475–85.

    PubMed  CAS  Google Scholar 

  17. Cox D. Regression models and life-tables. J R Stat Soc 1972; 34: 187–201.

    Google Scholar 

  18. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman and Hall, 1984.

    Google Scholar 

  19. Blake PG, Sombolos K, Abraham G et al Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients. Kidney Int 1991; 39: 700–6.

    Article  PubMed  CAS  Google Scholar 

  20. Teehan BP, Scheifler CR, Brown J. Urea kinetic modelling is an appropriate assessment of adequacy. Semin Dial 1992; 5: 189–92.

    Article  Google Scholar 

  21. DeAlvarro F, Bajo MA, Alvarez-Ude F et al Does Kt/V have the same predictive value as in HD? A multicentre study. Adv Petit Dial 1992; 8: 93–7.

    Google Scholar 

  22. Lameire NH, Vanholder R, Veyt D, Lambert MC, Ringoir S. A longitudinal 5 year survey of kinetic parameters in CAPD patients. Kidney Int 1992; 42: 426–32.

    Article  PubMed  CAS  Google Scholar 

  23. Maiorca R, Brunori G, Zubani R et al Predictive value of adequacy of dialysis and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10: 2295–305.

    Article  PubMed  CAS  Google Scholar 

  24. Popovich RP, Moncrief JW, Dechard JB, Bomar JB, Pyle WK. The definition of a novel portable/wearable equilibrium peritoneal dialysis technique. ASAIO Trans 1976; 5: 64.

    Google Scholar 

  25. Popovich RP, Moncrief JW. Kinetic modelling of peritoneal transport. Contrib Nephol 1979; 17: 59–72.

    CAS  Google Scholar 

  26. Churchill DN: Adequacy of peritoneal dialysis: how much dialysis do we need? Kidney Int 1994; 46 (suppl. 48): S2–6.

    Google Scholar 

  27. Teehan BP, Scheifler CR, Sigler MH, Gilgore GS. A quantitative approach to the CAPD prescription. Petit Dial Bull 1985; 5: 152–6.

    Google Scholar 

  28. Keshaviah PR. Adequacy of CAPD: a quantitative approach. Kidney Int 1992; 42 (suppl. 38): S160–4.

    Google Scholar 

  29. NKF-DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. New York: National Kidney Foundation, 1997.

    Google Scholar 

  30. Gotch F. Update on the randomized multicentre trial on CAPD prescription. Presented at Symposium on Dialysis Schedule in Hemodialysis and Peritoneal Dialysis. Perugia, Italy, 24–26 November 1996.

    Google Scholar 

  31. Churchill DN. An evidence-based approach to earlier initiation of dialysis. Am J Kidney Dis 1997; 30: 899–906.

    Article  PubMed  CAS  Google Scholar 

  32. Pierratos A, Ouwendyk M, Francoeur R et al Nocturnal hemodialysis: three year experience. J Am Soc Nephrol 1998; 9: 859–68.

    PubMed  CAS  Google Scholar 

  33. Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 1995; 6: 1386–91.

    PubMed  CAS  Google Scholar 

  34. Levey AS, Greene T, Burkart J for the MDRD Study Group. Comprehensive assessment of the level of renal function at the initiation of dialysis in the MDRD study. J Am Soc Nephrol 1998; 9: 153A.

    Google Scholar 

  35. Cowie CC, Port Fk, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 1989; 321: 1074–9.

    CAS  Google Scholar 

  36. Bernardini J, Piraino B. Measuring compliance with prescribed exchanges in CAPD and CCPD patients. Petit Dial Int 1997; 17: 338–42.

    CAS  Google Scholar 

  37. Fine A. Compliance with the CAPD prescription is good. Petit Dial Int 1997; 17: 343–6.

    CAS  Google Scholar 

  38. Blake P, Korbet S, Blake R et al Admitted non-compliance with CAPD exchanges is more common in US than Canadian patients. J Am Soc Nephrol 1997; 8: 278A.

    Google Scholar 

  39. Keane WF, Collins AJ. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 1994; 24: 1010–18.

    PubMed  CAS  Google Scholar 

  40. Barrett BJ, Parfrey PS, Morgan J et al Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis 1997; 29: 214–22.

    Article  PubMed  CAS  Google Scholar 

  41. Twardowski ZJ, Nolph KD, Khanna R. Peritoneal equilibrium test. Petit Dial Bull 1987; 7: 138–47.

    Google Scholar 

  42. Nolph KD, Moore HL, Prowant B. Continuous peritoneal dialysis with a high flux membrane. ASAIO J 1993; 39: 904–9.

    CAS  Google Scholar 

  43. Heaf J. CAPD adequacy and dialysis morbidity: detrimental effect of a high peritoneal equilibration rate. Renal Fail 1995; 17: 575–87.

    Article  CAS  Google Scholar 

  44. Wu C, Huang C, Huang J, Wu M, Leu M. High flux peritoneal membrane is a risk factor in survival of CAPD treatment. Adv Petit Dial 1996; 12: 105–9.

    CAS  Google Scholar 

  45. Fried L. Higher membrane permeability predicts poorer patient survival. Petit Dial Int 1997; 17: 387–89.

    CAS  Google Scholar 

  46. Wang T, Heimburger O, Waniewski J, Bergstrom J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998; 13: 1242–9.

    Article  PubMed  CAS  Google Scholar 

  47. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival independently of residual renal function. Nephrol Dial Transplant 1998; 13: 962–8.

    Article  PubMed  CAS  Google Scholar 

  48. Twardowski ZJ, Nolph KD, Khanna R, Gluck Z, Prowant BF, Ryan LP. Daily clearances with CAPD and NIPD. ASAIO Trans 1986; 23: 575–9.

    Article  Google Scholar 

Download references

Authors
  1. D. N. Churchill
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Renal Medicine, Manchester Royal Infirmary, Oxford Road, M13 9WL, Manchester, UK

    R. Gokal

  2. Division of Nephrology, Department of Medicine, MA 436 Health Services Centre, University of Missouri-Columbia, 65212, Columbia, MO, USA

    R. Khanna

  3. Academisch Medisch Centrum, Amsterdam, The Netherlands

    R. Th. Krediet

  4. Department of Internal Medicine, MA 436 Health Sciences Center, University of Missouri-Columbia, 65212, Columbia, MO, USA

    K. D. Nolph

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Churchill, D.N. (2000). Implications of the Canada—USA (CANUSA) multicentre trial. In: Gokal, R., Khanna, R., Krediet, R.T., Nolph, K.D. (eds) Textbook of Peritoneal Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-3225-3_27

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-3225-3_27

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-3227-7

  • Online ISBN: 978-94-017-3225-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation